Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
The report also found that medical device companies are taking “huge gambles” in the area of risk management.
Treatment can no longer be one dimensional.
AdvaMed states that the huge tax increase will have a significant impact on employment and investment.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
Stakeholders warn that more EtO facility closures could have a catastrophic result.
Whatever the demands of international regulators, it is public expectations that will ultimately dictate the need for life sciences companies to prepare complete and accurate product data that patients and healthcare providers can scrutinize on demand.
The deal is expected to close in the second half of 2020, but one analyst expects the transaction will raise antitrust issues in the United States.
The future of eye care will sit at the intersection of the digital and physical worlds.
The White House issued a statement on the president’s intent to nominate Hahn, who is currently the chief medical executive at The University of Texas MD Anderson Cancer Center in Houston.